Catalyst Wire Dossier Catalyst Wire Dossier

Dovato

dolutegravir/lamivudine · ViiV Healthcare
Drug timelines are a Plus or Pro feature.

26 regulatory and trial events tracked for Dovato, covering 2019-04-08 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: B/F/TAF to DTG/3TC Switch Study [Phase 3]

See pricing